Viewing Study NCT05506332


Ignite Creation Date: 2025-12-24 @ 9:41 PM
Ignite Modification Date: 2026-06-05 @ 10:26 AM
Study NCT ID: NCT05506332
Status: RECRUITING
Last Update Posted: 2022-08-18
First Post: 2022-08-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Treatment With ABT-199 (Venetoclax) and Purine Analogues in Relapsed/Refractory Acute Myeloid Leukemia
Sponsor: University Hospital, Antwerp
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myeloid Leukemia, in Relapse View
None Acute Myeloid Leukemia Refractory View
Keywords: